Seeyond’s Exact Sciences EXAS Stock Holding History

Seeyond’s Portfolio EXAS Stock Details EXAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	$164K	Sell	3,303 -8,789	-73%	-$359K	0.02%	515
2022 Q3	$392K	Buy	12,092 +7,288	+152%	+$300K	0.05%	460
2022 Q2	$189K	Sell	4,804 -97	-2%	-$5.19K	0.02%	539
2022 Q1	$342K	Sell	4,901 -147	-3%	-$10.7K	0.03%	505
2021 Q4	$392K	Buy	5,048 +3,831	+315%	+$338K	0.04%	511
2021 Q3	$116K	Sell	1,217 -13	-1%	-$1.37K	0.01%	576
2021 Q2	$152K	Buy	1,230 +6	+0.5%	+$716	0.01%	558
2021 Q1	$161K	Sell	1,224 -1,798	-59%	-$246K	0.02%	565
2020 Q4	$400K	Buy	3,022 +1,791	+145%	+$217K	0.04%	477
2020 Q3	$126K	Sell	1,231 -1,919	-61%	-$166K	0.01%	559
2020 Q2	$274K	Buy	3,150 +2,146	+214%	+$171K	0.03%	502
2020 Q1	$124K	Sell	1,004 -5	-0.5%	-$406	0.02%	541
2019 Q4	$93K	Hold	1,009	–	–	0.01%	617
2019 Q3	$91K	Hold	1,009	–	–	0.01%	612
2019 Q2	$119K	Buy	+1,009	New	+$102K	0.01%	588

Other funds holding EXAS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Seeyond's EXAS Position: Q4 2022 in Review

Seeyond reduced its Exact Sciences (EXAS) stake by 73% in Q4 2022, selling an estimated $359K and leaving 3,303 shares worth $164K. The position accounts for 0.02% of the portfolio, ranked #515.

Seeyond first reported a position in EXAS in Q2 2019 and has held it in 15 quarters since. The position peaked at $400K in Q4 2020. 550 funds tracked by Wall St. Rank hold EXAS as of Q4 2022.

Seeyond held 3,303 shares of Exact Sciences worth $164K as of Q4 2022.
Seeyond sold 8,789 Exact Sciences shares in Q4 2022, an estimated $359K.
Exact Sciences made up 0.02% of Seeyond's portfolio in Q4 2022, its #515 holding.
Seeyond first reported a position in Exact Sciences in Q2 2019 and has held it in 15 quarters since.
Seeyond's Exact Sciences position peaked at $400K in Q4 2020.
550 funds tracked by Wall St. Rank held Exact Sciences as of Q4 2022.

Based on Seeyond's 13F filing for Q4 2022, filed 13 Feb 2023.